Stock Research for PRTA


Featured Broker: Ally Invest

Get the due diligence for another stock.


PRTA Stock Chart & Research Data

The PRTA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PRTA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PRTA Due diligence Resources & Stock Charts

The PRTA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PRTA Detailed Price Forecast - CNN Money CNN View PRTA Detailed Summary - Google Finance
Yahoo View PRTA Detailed Summary - Yahoo! Finance Zacks View PRTA Stock Research & Analysis -

Stock Analysis

TradeIdeas View PRTA Trends & Analysis - Trade-Ideas Barrons View PRTA Major Holders - Barrons
NASDAQ View PRTA Call Transcripts - NASDAQ Seeking View PRTA Breaking News & Analysis - Seeking Alpha
Spotlight View PRTA Annual Report - OTC Report View PRTA OTC Short Report -
TradeKing View PRTA Fundamentals - TradeKing Charts View PRTA SEC Filings - Bar Chart
WSJ View Historical Prices for PRTA - The WSJ Morningstar View Performance/Total Return for PRTA - Morningstar
MarketWatch View the Analyst Estimates for PRTA - MarketWatch CNBC View the Earnings History for PRTA - CNBC
StockMarketWatch View the PRTA Earnings - StockMarketWatch MacroAxis View PRTA Buy or Sell Recommendations - MacroAxis
Bullish View the PRTA Bullish Patterns - American Bulls Short Pains View PRTA Short Pain Metrics -

Social Media Mentions

StockTwits View PRTA Stock Mentions - StockTwits PennyStocks View PRTA Stock Mentions - PennyStockTweets
Twitter View PRTA Stock Mentions - Twitter Invest Hub View PRTA Investment Forum News - Investor Hub
Yahoo View PRTA Stock Mentions - Yahoo! Message Board Seeking Alpha View PRTA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PRTA - Insider Cow View Insider Transactions for PRTA - Insider Cow
CNBC View PRTA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PRTA - OTC Markets
Yahoo View Insider Transactions for PRTA - Yahoo! Finance NASDAQ View Institutional Holdings for PRTA - NASDAQ

Stock Charts

FinViz View PRTA Stock Insight & Charts - StockCharts View PRTA Investment Charts -
BarChart View PRTA Stock Overview & Charts - BarChart Trading View View PRTA User Generated Charts - Trading View

Latest Financial News for PRTA

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Prothena Corporation plc (PRTA) & Lead Plaintiff Deadline - September 17, 2018
Posted on Wednesday July 18, 2018

NEW YORK , July 18, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Prothena Corporation plc ("Prothena" ...

Labaton Sucharow LLP Files Securities Class Action Lawsuit on Behalf of Prothena Corporation plc Investors
Posted on Tuesday July 17, 2018

NEW YORK, July 17, 2018-- Labaton Sucharow LLP announces that on July 16, 2018, it filed a securities class action lawsuit on behalf of its client Granite Point Capital against Prothena Corporation plc, ...

Robbins Arroyo LLP: Prothena Corporation Public Limited Company (PRTA) Misled Shareholders According to a Recently Filed Class Action
Posted on Tuesday July 17, 2018

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of Prothena Corporation Public Limited Company (PRTA) filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between October 15, 2015 and April 20, 2018. Prothena develops and sells novel immunotherapy treatment. Prothena's principal asset - NEOD001 - is a monoclonal antibody designed to treat amyloid light chain amyloidosis ("AL amyloidosis"), which can lead to organ failure and death.

CLASS ACTION DEADLINE MONDAY for PRTA and FLR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Posted on Monday July 16, 2018

NEW YORK, July 16, 2018-- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.